Cholinergic Agonists:
Overview:
-
Cholinergic neurons: Primarily found in the parasympathetic system but also involved in sympathetic innervation of sweat glands and blood vessels in skeletal muscle.
-
Cholinergic neurotransmission involves six major steps.
Steps of Cholinergic Neurotransmission
-
Choline Uptake
-
Choline is transported into the neuron by an energy- and sodium-dependent transport system.
-
-
Acetylcholine (ACh) Synthesis
-
Choline reacts with acetyl coenzyme A (Acetyl-CoA) to form acetylcholine.
-
Enzyme: Choline acetyltransferase (ChAT).
-
-
Storage
-
Acetylcholine is transported into presynaptic vesicles, where it is protected from degradation.
-
-
Release
-
An action potential opens voltage-sensitive calcium channels → calcium influx → vesicle fusion with membrane → ACh release.
-
-
Receptor Binding
-
ACh binds to:
-
Postsynaptic receptors → cholinergic response.
-
Presynaptic receptors → inhibits further ACh release (negative feedback).
-
-
-
Degradation & Recycling
-
Enzyme: Acetylcholinesterase (AChE) breaks ACh into acetate and choline.
-
Free choline is taken up again by the presynaptic neuron → cycle repeats.
-
Cholinergic Receptors
Two main types:
-
Muscarinic receptors (M)
-
Nicotinic receptors (N)
Muscarinic Receptors
-
Have high affinity for muscarine.
-
Five subtypes: M₁–M₅ (functionally defined: M₁, M₂, M₃).
| Receptor | Location | G-Protein Type | Effect |
|---|---|---|---|
| M₁ | Neurons, gastric glands | Gq | ↑ intracellular Ca²⁺ → secretion, neurotransmission |
| M₂ | Cardiac cells | Gi | Opens K⁺ channels → hyperpolarization → ↓ HR |
| M₃ | Smooth muscle (eye, lungs, GI), exocrine glands | Gq | ↑ Ca²⁺ → contraction, secretion |
Summary:
-
M₁/M₃ (Gq) → ↑ Ca²⁺ → contraction/secretion.
-
M₂ (Gi) → ↑ K⁺ conductance → ↓ HR.
Nicotinic Receptors
-
High affinity for nicotine.
-
Ligand-gated ion channels.
-
ACh binding → conformational change → Na⁺ influx → depolarization.
| Type | Location | Function |
|---|---|---|
| Nm | Neuromuscular junction | Muscle contraction |
| Nn | CNS & autonomic ganglia | Transmission of cholinergic signals |
Cholinergic Agonist Drugs
Divided into three groups:
-
Direct-acting
-
Indirect-acting (Reversible)
-
Indirect-acting (Irreversible)
1. Direct-Acting Agonists
-
Mimic ACh by binding directly to muscarinic or nicotinic receptors.
| Drug | Notes | Uses |
|---|---|---|
| Acetylcholine | Nonspecific, rapidly inactivated by cholinesterase → limited use. | Ophthalmic: produce miosis during eye surgery. |
| Carbachol | Resistant to AChE → longer duration. | Locally in eye surgery → miosis, ↓ intraocular pressure. |
| Pilocarpine | Acts on eye smooth muscle; ↑ aqueous outflow → ↓ IOP. | Acute glaucoma attacks. |
| Bethanechol | Selective for urinary & GI tracts. | Urinary retention, GI atony (oral or SC). |
2. Indirect-Acting (Reversible) Agonists
-
Bind to acetylcholinesterase, preventing ACh breakdown → accumulation of ACh in synapse.
| Drug | Duration | Notes | Uses |
|---|---|---|---|
| Edrophonium | Very short (10–20 min) | Reversibly binds AChE | Diagnosis of myasthenia gravis (↑ muscle strength after admin). |
| Physostigmine | Intermediate (30 min–2 hr) | Stimulates both N & M receptors; crosses BBB. | Antidote for anticholinergic overdose (e.g., Atropine). |
| Neostigmine | Intermediate; more polar → no CNS entry. | Poor GI absorption. | Myasthenia gravis, stimulate bladder/GI, reverse NM blockade. |
| Pyridostigmine | Similar to Neostigmine; longer acting. | — | Maintenance therapy for myasthenia gravis. |
| Donepezil, Rivastigmine, Galantamine | Central-acting agents. | Enhance cholinergic function in CNS. | Alzheimer’s disease (symptomatic relief only). |
3. Indirect Acting (Irreversible) Agonists
-
Form covalent bonds with AChE → long-lasting enzyme inhibition.
-
Many are toxic nerve agents (e.g., Sarin gas).
| Drug | Notes | Use |
|---|---|---|
| Echothiophate | Long acting; causes strong cholinergic stimulation. | Rarely used; open-angle glaucoma only (due to side effects). |
Adverse Effects of Cholinergic Agonists
Caused by overstimulation of cholinergic receptors.
Mnemonic: DUMBBELLS
| Effect | Description |
|---|---|
| D | Diarrhea |
| U | Urination |
| M | Miosis, Muscle weakness |
| B | Bronchorrhea |
| B | Bradycardia |
| E | Emesis |
| L | Lacrimation |
| L | Lethargy (sometimes listed as salivation/secretions) |
| S | Salivation |
Major Takeaways:
-
AChE inhibitors ↑ ACh at synapse → enhanced parasympathetic tone.
-
M₁, M₂, M₃ receptors mediate most clinically relevant effects.
-
Direct agonists act on receptors; indirect inhibit breakdown of ACh.
-
Reversible inhibitors used therapeutically; irreversible often toxic.
-
DUMBBELLS mnemonic helps recall major side effects.
No comments:
Post a Comment